Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT00787696
Other study ID # R01DA17509-4
Secondary ID R01DA017509
Status Completed
Phase Phase 1/Phase 2
First received November 6, 2008
Last updated October 19, 2011
Start date September 2003
Est. completion date December 2009

Study information

Verified date October 2011
Source Mississippi State University
Contact n/a
Is FDA regulated No
Health authority United States: Federal Government
Study type Interventional

Clinical Trial Summary

This project assesses the efficacy of an HIV prevention program with adolescent females incarcerated in the Mississippi training school for girls. Participants in both the health education control group and the HIV prevention group will increase health knowledge as a result of their participation in the health classes while incarcerated. However, participants in the HIV prevention group will increase their condom application, assertiveness, and communication skills relative to girls in the health education only group. In addition, after release from the training school, participants in the HIV prevention group will report lower sexual risk behaviors and will have lower rates of infection with chlamydia and gonorrhea during the 12-month follow-up period than participants in the health education only group.


Description:

This study is a longitudinal analysis of STD/HIV exposure among adolescent female offenders in Mississippi, a population that is disproportionately African American, and at higher risk than adolescents in general due to their propensity to engage in a variety of risk-taking behaviors, earlier onset of sexual behaviors, and the greater prevalence of mental disorders, substance abuse disorders, maltreatment, and family dysfunction. Based on social cognitive theory and Fisher and Fisher's (1992) IMB (Information, Motivation, and Behavioral skills) model, we will evaluate a drug abuse related HIV risk reduction intervention and compare outcomes against a STD/HIV information and health education control condition.

Approximately 400 females committed to the state reformatory/training school for girls will be recruited for participation. The research design will consist of alternating cohort/waves of about 50 subjects each. One treatment condition will be administered at a time with a washout period between cohort/waves. Over a three year period, one half of subjects will get 18 hours of STD/HIV prevention and one half will get 18 hours of Health Education. All subjects will receive one individual counseling session designed to enhance motivation for behavioral change just prior to release from training school. Before and after the intervention, subjects' social competency skills, condom application skills, and health knowledge will be measured. Before intervention and at 6-month and 12-month follow-up, self-report measures of alcohol and drug use, condom use, sexual risk behaviors, and measures of victimization, partner risk, condom attitudes, self-efficacy, and communication related to condom use and risk reduction will be collected. Urine tests for the detection of 2 STDs (chlamydia and gonorrhea) will also be performed at admission to Columbia Training School and at 6-month and 12-month follow-up.


Recruitment information / eligibility

Status Completed
Enrollment 333
Est. completion date December 2009
Est. primary completion date December 2008
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Female
Age group 13 Years to 18 Years
Eligibility Inclusion Criteria:

- Female, ages 13 to 17 years, committed to Columbia Training School, who provide written informed assent.

Exclusion Criteria:

- Acute or chronic physically illness that would preclude participation as determined by facility physician; placement in maximum security unit; study participation during a prior commitment

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Prevention


Related Conditions & MeSH terms


Intervention

Behavioral:
Cognitive-behavioral HIV/STD risk reduction
18 60-minute group sessions plus 1 individual health and safety planning session

Locations

Country Name City State
United States Columbia Training School Columbia Mississippi

Sponsors (2)

Lead Sponsor Collaborator
Mississippi State University National Institute on Drug Abuse (NIDA)

Country where clinical trial is conducted

United States, 

References & Publications (1)

Robertson AA, St Lawrence J, Morse DT, Baird-Thomas C, Liew H, Gresham K. The Healthy Teen Girls project: comparison of health education and STD risk reduction intervention for incarcerated adolescent females. Health Educ Behav. 2011 Jun;38(3):241-50. doi — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary number of partners and frequency of sexual risk behaviors Sexual behaviors included condom use in the 3 months prior to each assessment. Unprotected sex occasions (USOs) was calculated by subtracting the number of condom-protected vaginal and anal intercourse occasions from the total number of vaginal and anal intercourse occasions. Sex under the influence is the number of times participant reported sexual intercourse after drinking alcohol or using another drug. Safer sex was categorized as sexually abstinent or consistent condom use. at 6 & 12 months No
Primary infection with chlamydia or gonorrhea one year No
Secondary reproductive health knowledge Assessed as the number of correct answers to 37 treu/false and multiple choice questions pre and post-intervention No
Secondary condom application skill Measured by observing participants apply and remove a condom from a penile model and a 10-item checklist pre and post-intervention No
Secondary Communication skills Assessed during three role-play vignettes that place the respondent in a high-risk sexual or drug use situation and asked them to respond to a series of three escalating prompts as though the situation was actually happening. pre and post-intervention No
Secondary Perceived barriers to condom use assessed using the Condom Barrier Scale (St. Lawrence, Chapdeline, et al., 1999) at baseline, 6 and 12 month follow-up No
See also
  Status Clinical Trial Phase
Completed NCT03403569 - Safety and Efficacy of Triptolide Wilfordii in New Onset HIV-1 Infection Phase 3
Completed NCT02433743 - Impact of RUTF on Body Composition, Anemia and Zinc Status of PLWHA N/A
Recruiting NCT02753049 - Adherence Connection for Counseling, Education, and Support N/A
Completed NCT01360762 - Prophylaxis of Visceral Leishmaniasis Relapses in HIV Co-infected Patients With Pentamidine: a Cohort Study Phase 3
Recruiting NCT03147859 - Vedolizumab Treatment in Antiretroviral Drug Treated Chronic HIV Infection Phase 2
Recruiting NCT04297488 - Probiotic Supplementation for Those Immune Non-responders With HIV-1 Infection N/A
Completed NCT01827540 - Study of Dolutegravir (DTG) on PK of Cenicriviroc (CVC), and CVC on PK of DTG & on a Single Dose of Midazolam Phase 1
Completed NCT01475890 - Vitamin D Supplementation in HIV Phase 2/Phase 3
Recruiting NCT05947539 - Improving HIV Care Engagement Among Ugandan Adolescent Girls and Young Women: The Kisoboka Mukwano Intervention N/A
Withdrawn NCT01442428 - Paradoxical Tuberculosis Immune Reconstitution Inflammatory Syndrome (TB-IRIS) Treatment Trial Phase 2/Phase 3
Completed NCT02496793 - Community-Based Peer Facilitator Intervention (Zimbabwe) N/A
Completed NCT03069235 - Promoting Exclusive Breastfeeding Among HIV Infected Women in a PMTCT Program N/A
Completed NCT03794648 - The Effectiveness of a Mobile Interactive Supervised Therapy (MIST) Intervention for Improving Adherence to HIV Medication N/A
Withdrawn NCT04183738 - Inflammation and Co-Infections in D²EFT Phase 4
Enrolling by invitation NCT03919695 - Development of an Intervention to Reduce Heavy Drinking and Improve HIV Care Engagement Among Fisherfolk in Uganda N/A
Recruiting NCT04215926 - NAFLD in HIV-infected Patients
Completed NCT01406626 - Effectiveness of Peer Navigation to Link Released HIV+ Jail Inmates to HIV Care N/A
Completed NCT04371835 - COHIVE: Coronavirus (COVID-19) Outcomes in HIV Evaluation in Resource Limited Settings
Completed NCT01140633 - Novel Measures and Theory of Pediatric Antiretroviral Therapy Adherence in Uganda N/A
Enrolling by invitation NCT04373551 - WeExPAnd: PrEP Demonstration Project Among Women at Risk for HIV Infection - Preexposure Prophylaxis (PrEP) N/A